Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR

Clinical trial NCT04785742 · UNKNOWN

Trial details

NCT number: NCT04785742
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Safety of Almonertinib

Start date: 2020-12-31
Primary completion: 2023-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.